Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Metastatic Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683403
What this trial is testing

Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Fudan University 138
Testing effectiveness (Phase 2)Looking for participantsNCT07133750
What this trial is testing

PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
CRC (Colorectal Cancer)
Biotheus Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00104689
What this trial is testing

Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
UNICANCER 60
Testing effectiveness (Phase 2)Study completedNCT01276379
What this trial is testing

Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab

Who this might be right for
Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo 221
Testing effectiveness (Phase 2)Study completedNCT00467142
What this trial is testing

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colorectal Cancer
Institut Bergonié 62
Testing effectiveness (Phase 2)Ended earlyNCT00531115
What this trial is testing

Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 28
Testing effectiveness (Phase 2)Study completedNCT03142516
What this trial is testing

FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status

Who this might be right for
Colorectal NeoplasmsColorectal CarcinomaColorectal Cancer Metastatic+1 more
Grupo Espanol Multidisciplinario del Cancer Digestivo 20
Testing effectiveness (Phase 2)Study completedNCT00851084
What this trial is testing

Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsNeoplasm Metastasis
Sanofi 268
Not applicableStudy completedNCT00984048
What this trial is testing

Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jewish General Hospital 160
Early research (Phase 1)Study completedNCT00532909
What this trial is testing

Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer

Who this might be right for
Anal, Colon, and Rectal CancersColorectal NeoplasmsColon/Rectal Cancer
Branimir Sikic 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07515963
What this trial is testing

FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases.

Who this might be right for
Colo-rectal Cancer
Zhongnan Hospital 24
Testing effectiveness (Phase 2)Study completedNCT01322152
What this trial is testing

Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fudan University 52
Large-scale testing (Phase 3)UnknownNCT05378867
What this trial is testing

A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Zhejiang Teruisi Pharmaceutical Inc. 126
Large-scale testing (Phase 3)Ended earlyNCT00544700
What this trial is testing

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Swiss Cancer Institute 265
Testing effectiveness (Phase 2)UnknownNCT02515734
What this trial is testing

FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab

Who this might be right for
Colorectal Cancer
Japan Clinical Cancer Research Organization 360
Post-approval studies (Phase 4)Ended earlyNCT00114946
What this trial is testing

Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Genentech, Inc. 800
Large-scale testing (Phase 3)Study completedNCT02934529
What this trial is testing

Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab

Who this might be right for
Metastatic Colorectal Cancer
Ludwig-Maximilians - University of Munich 673
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000305
What this trial is testing

Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Tao Zhang 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04068610
What this trial is testing

COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC

Who this might be right for
Metastatic Microsatellite-stable Colorectal Cancer
MedImmune LLC 61
Large-scale testing (Phase 3)Looking for participantsNCT05253651
What this trial is testing

Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer 400
Next Page